Rousseau J J, Lust C A, Brucher J M
Service de Neurologie et de Neurophysiologie Clinique, Centre Hospitalier de Sainte-Ode.
Acta Neurol Belg. 1987 Aug-Oct;87(4):197-206.
A 65-year-old male patient with chronic obstructive long disease developed a severe motor and sensory polyneuropathy during the treatment with almitrine bismesylate (Vectarion). Electrophysiological and neuropathological investigations demonstrated a distal axonopathy. A medicamentous origin was suspected since other causal factors were lacking. Eight months after stopping of treatment, the functional recovery was complete. The authors discuss the recent data recorded in the literature concerning the neurological complications induced by this new drug, which is increasingly administered in diseases of the respiratory tract.
一名65岁患有慢性阻塞性肺病的男性患者在使用二甲磺酸阿米三嗪(抗眩晕药)治疗期间出现了严重的运动和感觉性多发性神经病。电生理和神经病理学检查显示为远端轴索性神经病。由于缺乏其他病因,怀疑是药物所致。停药8个月后,功能完全恢复。作者讨论了文献中记录的有关这种新药引起的神经并发症的最新数据,这种新药在呼吸道疾病中的应用越来越多。